Physician profile
Amy Puhl
NPI 1861957532
$1,522.38
in general payments reported to CMS, 2019-2025
13 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $180 · 2023: $459 · 2024: $533 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.41 |
| Education | $107.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $573.52 | 2022-2025 | Tremfya, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $253.86 | 2023-2024 | Trulance |
| Lilly USA, LLC | $120.30 | 2024 | Omvoh |
| Genzyme Corporation | $107.24 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.78 | 2023-2025 | Entyvio, Eohilia |
| Regeneron Healthcare Solutions, INC. | $90.47 | 2022-2025 | Dupixent |
| Ardelyx, INC. | $74.58 | 2022-2025 | Ibsrela |
| Abbvie INC. | $58.76 | 2023-2024 | |
| Braintree Laboratories, INC. | $38.81 | 2023-2024 | Suflave |
| Pfizer INC. | $28.41 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.49 | 2023 | Cyltezo |
| Celgene Corporation | $25.30 | 2023 | Zeposia |
| Ipsen Biopharmaceuticals, INC | $18.86 | 2025 | Iqirvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Puhl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.